BioSpace News Archive

Female Pelvic Implants Market: Rising prevalence of pelvic organ prolapse is expected to drive the market

Devices that are used to treat pelvic organ prolapse or stress urinary incontinence are referred to as female pelvic implants.

February 1, 2022

·

7 min read

Anesthesia Laryngeal Masks Market: Disposable anesthesia laryngeal masks segment is anticipated to expand at a higher CAGR during the forecast period

Anesthesia laryngeal mask is a medical device that keeps a patient’s airway open during anesthesia. This device maintains upper airway patency during general anesthesia or unconsciousness.

February 1, 2022

·

6 min read

Adenosine Injection Market: Growing awareness about cardiac stress testsare projected to fuel the growth of the market

Adenosine is an endogenous nucleoside present in all cells of the body. It is present in the form of white crystalline powder that is soluble in water and practically insoluble in alcohol.

February 1, 2022

·

6 min read

Sensorion to Present New Data on OTOF Gene Therapy at the Association for Research in Otolaryngology ARO 45th Annual MidWinter Meeting

Sensorion is pleased to announce its participation at the 2022 Association for Research in Otolaryngology MidWinter Meeting, where it will take part in a workshop and present a poster on gene therapy.

February 1, 2022

·

4 min read

Glycotope to spin-out its Service Business to the newly formed FyoniBio GmbH

Glycotope GmbH and CantonBio Deutschland GmbH announced the successful completion of CantonBio’s acquisition of Glycotope’s service business under the newly formed FyoniBio GmbH.

February 1, 2022

·

4 min read

Business

Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022

In the 2021 financial year, Novozymes delivers 6% organic sales growth – 7% organic sales growth in the fourth quarter alone – an EBIT-margin of 26.8%, and ROIC including goodwill of 19.3%.

February 1, 2022

·

4 min read

Biotech Bay

Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications

Twist Bioscience Corporation and Abcam announced a licensing agreement under which Abcam will use a proprietary Twist VHH phage library for antibody discovery, development and commercialization for diagnostic and research applications.

February 1, 2022

·

10 min read

Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases

Ethris GmbH, a leading biotechnology company pioneering transformative messenger RNA therapeutics, announced that it has raised $26.3 Million in a Series B financing round led by Laureus Capital.

February 1, 2022

·

4 min read

Drug Development

Reviva Pharmaceuticals Announces First Patients Dosed in Pivotal Phase 3 Study and Long-Term Safety Trial Evaluating Brilaroxazine for the Treatment of Schizophrenia

Reviva Pharmaceuticals Holdings, Inc. announced that the first patients have been dosed in a pivotal Phase 3 study and long-term safety trial to assess Reviva’s new chemical entity brilaroxazine for the treatment of subjects with an acute exacerbation of schizophrenia.

February 1, 2022

·

6 min read

BioMidwest

Exact Sciences to participate in February 2022 investor conferences

Exact Sciences Corp. announced that company management will participate in the following virtual conferences and invited investors to participate by webcast.

February 1, 2022

·

1 min read